{"id":"https://openalex.org/W2010142226","doi":"https://doi.org/10.1176/appi.psy.46.4.374","title":"Delirium Resolving Upon Switching From Risperidone to Quetiapine: Implication of CYP2D6 Genotype","display_name":"Delirium Resolving Upon Switching From Risperidone to Quetiapine: Implication of CYP2D6 Genotype","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W2010142226","doi":"https://doi.org/10.1176/appi.psy.46.4.374","mag":"2010142226","pmid":"https://pubmed.ncbi.nlm.nih.gov/16000684"},"language":"en","primary_location":{"id":"doi:10.1176/appi.psy.46.4.374","doi":"https://doi.org/10.1176/appi.psy.46.4.374","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.psy.46.4.374","pdf_url":null,"source":{"id":"https://openalex.org/S114257564","display_name":"Psychosomatics","issn_l":"0033-3182","issn":["0033-3182","1545-7206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychosomatics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Daiji Kato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daiji Kato","raw_affiliation_strings":["Yoshio Hirayasu, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yoshio Hirayasu, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106725433","display_name":"Chiaki Kawanishi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiaki Kawanishi","raw_affiliation_strings":["Yoshio Hirayasu, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yoshio Hirayasu, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032320667","display_name":"Ikuko Kishida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ikuko Kishida","raw_affiliation_strings":["Yoshio Hirayasu, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yoshio Hirayasu, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070883651","display_name":"Taku Furuno","orcid":"https://orcid.org/0000-0001-6735-1719","observed_orcids":["https://orcid.org/0000-0001-6735-1719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taku Furuno","raw_affiliation_strings":["Yoshio Hirayasu, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yoshio Hirayasu, Yokohama, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112305190","display_name":"Takehiko Matsumura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takehiko Matsumura","raw_affiliation_strings":["Yoshio Hirayasu, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yoshio Hirayasu, Yokohama, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000517345","display_name":"Hana Hasegawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hana Hasegawa","raw_affiliation_strings":["Yoshio Hirayasu, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yoshio Hirayasu, Yokohama, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.1288,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.77764744,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"46","issue":"4","first_page":"374","last_page":"375"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8687000274658203,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8687000274658203,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.10279999673366547,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10867","display_name":"Intensive Care Unit Cognitive Disorders","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delirium","display_name":"delirium","score":0.9789999723434448},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/cyp2d6-genotype","display_name":"CYP2D6 genotype","score":0.7870000004768372},{"id":"https://openalex.org/keywords/drug-switching","display_name":"drug switching","score":0.527999997138977},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cytochrome-p450-polymorphisms","display_name":"cytochrome P450 polymorphisms","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.9066410064697266},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.890703558921814},{"id":"https://openalex.org/C2779753318","wikidata":"https://www.wikidata.org/wiki/Q160796","display_name":"Delirium","level":2,"score":0.7306704521179199},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.6625851988792419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5847536325454712},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5653427839279175},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35120677947998047},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3261781930923462},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3248385190963745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31878477334976196},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.26423633098602295},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.20867910981178284},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11614131927490234},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003693","descriptor_name":"Delirium","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003693","descriptor_name":"Delirium","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1176/appi.psy.46.4.374","doi":"https://doi.org/10.1176/appi.psy.46.4.374","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.psy.46.4.374","pdf_url":null,"source":{"id":"https://openalex.org/S114257564","display_name":"Psychosomatics","issn_l":"0033-3182","issn":["0033-3182","1545-7206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychosomatics","raw_type":"journal-article"},{"id":"pmid:16000684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16000684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychosomatics","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1766115599","https://openalex.org/W2012554561","https://openalex.org/W2026864077","https://openalex.org/W2117977967","https://openalex.org/W2173116433","https://openalex.org/W2315190166","https://openalex.org/W4247526495"],"related_works":["https://openalex.org/W2989549503","https://openalex.org/W1979615566","https://openalex.org/W4395034506","https://openalex.org/W2890447146","https://openalex.org/W2014789073","https://openalex.org/W1975468150","https://openalex.org/W2110284416","https://openalex.org/W2036148886","https://openalex.org/W4210951162","https://openalex.org/W2002465967"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}